Lexington Lab Project Delayed by Biotech Slump
A 345,000-square-foot life science development in Lexington is being delayed because of declining industry demand and inflation.
A 345,000-square-foot life science development in Lexington is being delayed because of declining industry demand and inflation.
The first new life sciences building in Somerville’s Brickbottom neighborhood is poised to get underway after receiving received $192.5 million in financing.
Somerville’s Brickbottom is joining the ranks of local neighborhoods shedding their industrial pasts to accommodate life science expansion, spurring redevelopment of two warehouses as a new 200,000-square-foot lab complex.
Wheelock Street Capital is the latest institutional investor to buy into the budding life science cluster in Somerville’s Inner Belt.
A Lexington property that’s being redeveloped as 345,000 square feet of office and lab space has been acquired by New York developer North River Co. for $38.7 million.
Somerville’s Brickbottom neighborhood is the latest life science growth area to emerge, with the filing of plans by a New York developer for a 200,000-square-foot speculative lab and R&D building.
Somerville’s Inner Belt district checks many of the boxes that are in demand among commercial developers. And the 100-acre neighborhood is seeing signs it could transform under the weight of demand for life science space.
A warehouse in Somerville’s Brickbottom neighborhood that was converted into dozens of artists’ studios and makerspaces has been sold to a New York developer that’s been expanding its inner suburban Boston portfolio.
A pair of Malden mixed-use buildings in one of the city’s two opportunity zones have sold for nearly $12 million.
Burgess Properties Inc. announced the sale of both 180 Everett Ave. and 115 Carter St. in Chelsea to North River Co. LLC, an affiliated entity of Waterfront New York.